Two-year outcome of patients after a first hospitalization for heart failure: A national observational study

Arch Cardiovasc Dis. 2014 Mar;107(3):158-68. doi: 10.1016/j.acvd.2014.01.012. Epub 2014 Mar 21.

Abstract

Background: National population-based management and outcome data for patients of all ages hospitalized for heart failure have rarely been reported.

Aim: National population-based management and outcome of patients of all ages hospitalized for heart failure have rarely been reported. The present study reports these results, based on 77% of the French population, for patients hospitalized for the first time for heart failure in 2009.

Methods: The study population comprised French national health insurance general scheme beneficiaries hospitalized in 2009 with a principal diagnosis of heart failure, after exclusion of those hospitalized for heart failure between 2006 and 2008 or with a chronic disease status for heart failure. Data were collected from the national health insurance information system (SNIIRAM).

Results: A total of 69,958 patients (mean age, 78 years; 48% men) were studied. The hospital mortality rate was 6.4%, with 1-month, 1-year and 2-year survival rates of 89%, 71% and 60%, respectively. Heart failure and all-cause readmission-free rates were 55% and 43% at 1 year and 27% and 17% at 2 years, respectively. Compared with a reference sample of 600,000 subjects, the age- and sex-standardized relative risk of death was 29 (95% confidence interval [CI] 28-29) at 2 years, 82 (95% CI 72-94) in subjects aged<50 years and 3 (95% CI 3-3) in subjects aged ≥ 90 years. For subjects aged < 70 years who survived 1 month after discharge, factors associated with a reduction in the 2-year mortality rate were: female sex; age < 55 years; absence of co-morbidities; and use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, beta-blockers, lipid-lowering agents or oral anticoagulants during the month following discharge. Poor prognostic factors were treatment with a loop diuretic before or after hospitalization and readmission for heart failure within 1 month after discharge.

Conclusions: This large population-based study confirms the severe prognosis of heart failure and the need to promote the use of effective medications and management designed to improve survival.

Keywords: France; Heart failure; Hospitalisation; Hospitalization; Incidence; Insuffisance cardiaque; SNIIRAM.

Publication types

  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Cardiology
  • Cardiovascular Agents / therapeutic use
  • Cause of Death
  • Comorbidity
  • Disease Management
  • Female
  • Follow-Up Studies
  • France / epidemiology
  • Heart Failure / drug therapy
  • Heart Failure / mortality*
  • Hospitalization*
  • Humans
  • Hypolipidemic Agents / therapeutic use
  • Male
  • Middle Aged
  • National Health Programs
  • Patient Readmission / statistics & numerical data
  • Prognosis
  • Referral and Consultation
  • Risk Factors
  • Sodium Potassium Chloride Symporter Inhibitors / therapeutic use
  • Survival Rate
  • Treatment Outcome

Substances

  • Cardiovascular Agents
  • Hypolipidemic Agents
  • Sodium Potassium Chloride Symporter Inhibitors